$0.66
13.29% day before yesterday
Nasdaq, Nov 14, 10:12 pm CET

Harvard Bioscience, Inc. Stock price

$0.66
+0.24 56.82% 1M
+0.31 90.69% 6M
-1.45 68.74% YTD
-1.63 71.20% 1Y
-1.99 75.11% 3Y
-3.40 83.75% 5Y
-2.34 78.01% 10Y
-1.96 74.84% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
+0.08 13.29%

Key metrics

Basic
Market capitalization
$29.4m
Enterprise Value
$56.8m
Net debt
$27.4m
Cash
$7.4m
Shares outstanding
44.5m
Valuation (TTM | estimate)
P/E
negative | 25.9
P/S
0.3 | -
EV/Sales
0.6 | -
EV/FCF
13.8
P/B
1.9
Financial Health
Equity Ratio
50.0%
Return on Equity
-19.6%
ROCE
-15.6%
ROIC
-6.2%
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$88.8m | $87.2m
EBITDA
$1.0m | $7.0m
EBIT
$-3.9m | $-52.1m
Net Income
$-57.4m | $1.1m
Free Cash Flow
$4.1m
Growth (TTM | estimate)
Revenue
-12.2% | -7.4%
EBITDA
27.2% | 5,922.5%
EBIT
15.7% | -868.8%
Net Income
-437.5% | 109.2%
Free Cash Flow
-32.1%
Margin (TTM | estimate)
Gross
56.9%
EBITDA
1.2% | 8.0%
EBIT
-4.4%
Net
-64.7% | 1.3%
Free Cash Flow
4.7%
More
EPS
$-1.3
FCF per Share
$0.1
Short interest
17.1%
Employees
343
Rev per Employee
$270.0k
Show more

Is Harvard Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Harvard Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Harvard Bioscience, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Harvard Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
89 89
12% 12%
100%
- Direct Costs 38 38
9% 9%
43%
50 50
14% 14%
57%
- Selling and Administrative Expenses 40 40
14% 14%
45%
- Research and Development Expense 9.41 9.41
18% 18%
11%
1.03 1.03
27% 27%
1%
- Depreciation and Amortization 4.91 4.91
9% 9%
6%
EBIT (Operating Income) EBIT -3.88 -3.88
16% 16%
-4%
Net Profit -57 -57
438% 438%
-65%

In millions USD.

Don't miss a Thing! We will send you all news about Harvard Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Harvard Bioscience, Inc. Stock News

Neutral
Seeking Alpha
9 days ago
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants John Duke - President, CEO & Director Mark Frost - Interim CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Taylor Krafchik Lucas Baranowski - KeyBanc Capital Markets Inc., Research Division Bruce Jackson - The Benchmark Company, LLC, R...
Neutral
GlobeNewsWire
10 days ago
Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by Operations Company Expects to Refinance or Repay the Debt in the Fourth Quarter Fourth Quarter 2025 Guidance Reflects Increased Demand and Backlog, Improved Operations and Strong Financial Discipline HOLLISTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) ...
Neutral
GlobeNewsWire
17 days ago
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m.
More Harvard Bioscience, Inc. News

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Head office United States
CEO James Green
Employees 343
Founded 1901
Website www.harvardbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today